M K Proteins FY26 net profit falls 18.7% to ₹682.90 lakh

M K Proteins Limited reported an 18.7% decline in net profit to ₹682.90 lakh for the financial year ended March 31, 2026, despite a 43% increase in revenue from operations to ₹38287.52 lakh. The company’s board approved the audited standalone financial results for the quarter and year ended March 31, 2026, during a meeting held on May 29, 2026. The statutory auditors, M/s Subhash Sajal and Associates, issued an unmodified opinion on the audited standalone financial results.

For the quarter ended March 31, 2026, the company recorded a profit of ₹113.83 lakh, a decrease from ₹279.61 lakh in the corresponding period of the previous year. Revenue from operations for the quarter stood at ₹14594.06 lakh, compared to ₹13720.41 lakh in the year-ago quarter. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published the audited financial results in the Financial Express and Jansatta on June 01, 2026.

Financial Performance

The annual results show that while total income grew, expenditure increased significantly, impacting the bottom line. Total expenditure for FY26 rose to ₹37374.60 lakh from ₹25673.16 lakh in FY25. The cost of materials consumed was ₹28648.84 lakh, and purchases of stock-in-trade amounted to ₹7369.24 lakh.

Key Financial Metrics (FY26 vs FY25)

Metric	FY26 (₹ in Lakhs)	FY25 (₹ in Lakhs)
Revenue from Operations	38287.52	26770.60
Total Expenditure	37374.60	25673.16
Profit Before Tax	938.86	1145.10
Net Profit	682.90	839.74
Basic EPS	0.18	0.22

Auditor Appointments

The board re-appointed M/s. K. K. Sinha & Associates as Cost Auditors for the financial year 2026-27. Additionally, M/s. Jayant Bansal & Co., Chartered Accountants, were re-appointed as Internal Auditors for FY27. The company confirmed there were no outstanding defaults on loans and debt securities as of March 31, 2026.

Borrowings and Ratings

Outstanding borrowings as of March 31, 2026, stood at ₹36.19 crore, down from ₹37.75 crore in the previous year. The company holds an 'A' rating for both long-term and short-term bank facilities from CRISIL. M K Proteins confirmed it is not classified as a Large Corporate under SEBI regulations.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	-2.76%	-4.64%	-21.25%	-29.97%	+460.23%

M. K. Proteins Limited has notified the stock exchanges of a forthcoming Board of Directors meeting scheduled for Friday, May 29, 2026. The intimation, dated May 18, 2026, was filed pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was addressed to both the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.

Board Meeting Agenda

The Board meeting has been convened to consider and approve several key business items. The following matters are scheduled to be taken up at the meeting:

Agenda Item:	Details
Financial Results:	Audited Financial Results for the quarter and year ended March 31, 2026
Cost Auditor Re-appointment:	M/s. K. K. Sinha & Associates, Cost Accountants (Firm Regn. No. 100279) for FY2026-27
Internal Auditor Re-appointment:	M/s. Jayant Bansal & Co., Chartered Accountants for FY2026-27
Other Business:	Any other items with the permission of the Chairman

Trading Window Closure

In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, the Trading Window for trading in equity shares of M. K. Proteins Limited will remain closed until 48 hours after the declaration of the aforesaid financial results, following which it will reopen accordingly.

The intimation was signed by Neha Aggarwal, Company Secretary & Compliance Officer, on behalf of M. K. Proteins Limited, on May 18, 2026.